[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Kashish Parpiani [@kparpiani](/creator/twitter/kparpiani) on x 2873 followers Created: 2025-07-14 03:52:26 UTC China has a pipeline of more than XX late-stage obesity drug candidates under development, according to LEK Consulting. Several firms have licensed their drugs to US or European drugmakers like AstraZeneca Plc and Merck & Co for clinical development.  XXX engagements  **Related Topics** [drugs](/topic/drugs) [lek](/topic/lek) [china](/topic/china) [$azn](/topic/$azn) [stocks healthcare](/topic/stocks-healthcare) [$mrk](/topic/$mrk) [Post Link](https://x.com/kparpiani/status/1944605884220682370)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kashish Parpiani @kparpiani on x 2873 followers
Created: 2025-07-14 03:52:26 UTC
China has a pipeline of more than XX late-stage obesity drug candidates under development, according to LEK Consulting. Several firms have licensed their drugs to US or European drugmakers like AstraZeneca Plc and Merck & Co for clinical development.
XXX engagements
/post/tweet::1944605884220682370